Education
About Us
Working with TipRanks
Follow Us
Lisata Therapeutics (LSTA)
NASDAQ:LSTA
Earnings Data
Report Date
Feb 26, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.62Last Year’s EPS
-0.55Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
Lisata Therapeutics has made significant progress in its clinical programs and strategic partnerships, reflecting strong operational management and promising trial results. However, the need for additional capital for Phase III trials poses a significant challenge. The market's lack of response to positive developments highlights ongoing investor skepticism or broader market conditions.Company Guidance
Strategic Alliance with GATC Health
Lisata entered into a strategic alliance with GATC Health to use their advanced AI technology for drug discovery, identifying several development candidates for clinical development in 2026.
Nonexclusive License Agreement with Catalent
Executed a global license agreement with Catalent, granting them access to certepetide for use in their SMARTag ADC technology platform, enhancing tumor targeting and efficacy.
Phase IIb ASCEND Trial Positive Results
Presented positive preliminary data from both Cohorts A and B, showing positive trends in survival rates without increased adverse events, supporting further development of certepetide.
Operating Expense Reduction
Operating expenses decreased by 17.3% year-over-year, reflecting successful cost management strategies.
Cash Runway into 2027
The company has cash and cash equivalents of approximately $19 million, supporting operations into the first quarter of 2027.
LSTA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LSTA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $2.35 | $2.06 | -12.34% |
Aug 07, 2025 | $2.80 | $2.60 | -7.14% |
May 08, 2025 | $2.37 | $2.10 | -11.39% |
Feb 27, 2025 | $2.40 | $2.38 | -0.83% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Lisata Therapeutics (LSTA) report earnings?
Lisata Therapeutics (LSTA) is schdueled to report earning on Feb 26, 2026, After Close (Confirmed).
What is Lisata Therapeutics (LSTA) earnings time?
Lisata Therapeutics (LSTA) earnings time is at Feb 26, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LSTA EPS forecast?
LSTA EPS forecast for the fiscal quarter 2025 (Q4) is -0.62.